Ipamorelin 5mg research peptide lyophilised powder
Growth Hormone Secretagogues≥98%

Ipamorelin

5mg

£19.99

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist pentapeptide. Research has shown it stimulates growth hormone release without significantly affecting cortisol or prolactin, making it one of the most selective GH secretagogues available. Often paired with CJC-1295 in synergistic research. One of the most studied compounds in endocrinology. Supplied as lyophilised powder, third-party tested, lab certificate published on this page.

Published research on Ipamorelin is indexed on PubMed. See our full UK buyer's guide for Research Peptides.

Intended Use: Strictly for in-vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the MHRA or FDA. Buyer assumes full responsibility for safe handling and regulatory compliance.

VialsQuantityDiscount
First Research24%
Most Popular37%
Max Savings4-1010%

≥98%

Purity

LAB

Certified

SAME

Day Ship

Quantity

1
In Stock
Order now · Dispatched within 24 hours

Add £25.01 more for free UK delivery

Damaged or lost? Free reshipment guaranteed

Available as a Pre-Blended Vial

CJC-1295 + Ipamorelin 5+5mg

Pre-blended GHRH + GHRP research peptide vial. CJC-1295 (no DAC) and Ipamorelin combined.

£42.99

All components in a single lyophilised vial. One reconstitution, one inventory line, one CoA.

Research Use Only

This product is intended strictly for research and laboratory use only. Not for human consumption, medical use, or diagnostic purposes.

Certificate of Analysis

Third-party tested

LatestUKPL-367
Purity98.958%MethodHPLC-UV / MSLabChromate AnalyticsTestedNov 2025
View Lab Certificate
Test Methodology≥98% spec
IdentityRP-HPLC + ESI-MSPurityUV @ 220nm peak areaQuantityGravimetric vs labelRelease spec≥98% purity
Request Older CoA

Lyophilised Stability

24 months

Sealed at -20°C, light-protected

Reconstituted Stability

Up to 3 months

Stored at 2-8°C after mixing

Cold-Chain Shipping

Always

Dry-cold pack, Royal Mail Tracked 24

Important Notice

All compounds are sold individually and do not include research supplies. Products are provided in lyophilised (powder) form and require proper reconstitution before use in research settings.

Related Products

Ipamorelin Price (UK)

Ipamorelin 5mg is £19.99 per vial, supplied from stock in the UK with a third-party HPLC certificate published on this page. UK delivery is £4.50 by Royal Mail Tracked 24, or free once your basket reaches £45 (£25.01 away at this price). Orders placed before 2pm on a working day are dispatched the same day.

Ipamorelin · Price per vial
VialPriceCost per mgAvailability
Ipamorelin 5mgThis page£19.99£4.00In stock

Prices are in GBP and shown per vial as supplied, lyophilised, for in-vitro laboratory research only. Cost per mg is given so researchers can compare vial sizes on a like-for-like basis. Stock and pricing on this table are read live from our inventory, so they match the basket. See our FAQ for delivery and payment options, and quality & testing for how each batch is verified.

Product Specifications

CAS Number170851-70-4
Molecular Weight711.86 g/mol
Purity≥98% by HPLC
FormLyophilised powder

Research Overview

Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue (GHS). It acts by mimicking the endogenous hormone ghrelin and binding to the growth hormone secretagogue receptor type 1a (GHS-R1a) in the anterior pituitary gland. Ipamorelin is distinguished from other growth hormone releasing peptides (GHRPs) such as GHRP-2 and GHRP-6 by its exceptional selectivity, it stimulates growth hormone release without significantly elevating cortisol, prolactin, or adrenocorticotropic hormone (ACTH) levels. This selectivity makes Ipamorelin the most specific GHS available for endocrine research, minimising confounding hormonal variables in experimental designs. In current research practice, Ipamorelin is frequently studied in combination with CJC-1295 (modified GRF 1-29) for synergistic growth hormone secretion, Ipamorelin acting at the GHS receptor and CJC-1295 acting at the GHRH receptor to produce amplified pulsatile GH release through complementary receptor pathways.

The primary reference is Raun and colleagues (Eur J Endocrinol, 1998), the paper that introduced the molecule and established the property it is known for. They described it as the first growth hormone releasing peptide with a selectivity approaching that of GHRH itself, reporting growth hormone release without the accompanying ACTH and cortisol elevation characteristic of GHRP-6 and hexarelin. Structurally it is a pentapeptide with a C-terminal amide and two D-amino acids, both features contributing to protease resistance.

It was developed as a research compound under the code NNC 26-0161 and taken into a discontinued clinical study, so despite reaching human trials Ipamorelin holds no marketing authorisation in any jurisdiction. It is supplied here as a lyophilised research chemical for in-vitro laboratory use only.

Product Specifications

Ipamorelin · Technical Data
Molecular FormulaC₃₈H₄₉N₉O₅
Molecular Weight711.9 g/mol
Purity98.958% (Chromate Analytics, RP-HPLC)
BatchUKPL-367
Storage-20°C lyophilised, 2-8°C reconstituted
AppearanceWhite lyophilised powder
FormLyophilised powder

Laboratory Handling

  • Store lyophilised vials at -20°C. Reconstituted Ipamorelin should be refrigerated at 2-8°C and used within 4 weeks.
  • Reconstitute with bacteriostatic water. Direct the stream of water down the side of the vial and swirl gently.
  • Handle under aseptic conditions using sterile syringes. Wipe vial stopper with an alcohol swab before each use.
  • Avoid repeated freeze-thaw cycles. Prepare single-use aliquots where possible to maintain peptide integrity.

Frequently Asked Questions

Research Information

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue (GHS) that mimics ghrelin and binds to the growth hormone secretagogue receptor type 1a (GHS-R1a) in the anterior pituitary. Unlike GHRP-2 or GHRP-6, Ipamorelin stimulates GH release without significantly elevating cortisol, prolactin, or ACTH. Supplied as lyophilised powder for in-vitro research use only.

Ipamorelin Research Applications

Ipamorelin is studied in endocrine research focused on selective GH secretion, GHS-R1a receptor pharmacology, and pulsatile GH release kinetics. It is frequently combined with CJC-1295 (a GHRH analogue) to study synergistic GH release through complementary GHS and GHRH receptor pathways.

Reconstitution Guide

Allow vials to reach room temperature, then sterilise the rubber stopper of both the peptide vial and the bacteriostatic water vial with an alcohol swab. Slowly draw your bacteriostatic water into a sterile insulin syringe, then inject it gently down the inner glass wall of the peptide vial, never directly onto the lyophilised powder. Once added, gently swirl the vial in a slow circular motion until fully dissolved. Never shake or vortex. The solution should be clear and colourless. Label the vial with the reconstitution date and store immediately.

See our full peptide reconstitution guide and reconstitution calculator for step-by-step protocol.

Storage Instructions

Lyophilised vials should be stored at -20°C, protected from light and moisture, and remain stable for up to 24 months. Once reconstituted with bacteriostatic water, store the solution at 2-8°C (standard refrigerator) and use within approximately 3 months. For storage beyond that, prepare single-use aliquots at -20°C, where reconstituted peptide remains stable for up to 6 months. Avoid repeated freeze-thaw cycles and always handle under sterile laboratory conditions.

Frequently Asked Questions

Ipamorelin

5mg · £19.99